Hims Lawsuit 2026: FTC Sues Hims & Hers Over Data Sharing and Billing Practices
Quick Answer
- Yes, the Hims lawsuit is real: the FTC filed it in federal court on July 29, 2026, alongside Utah and California officials.
- There is no confirmed payout amount yet. The case is pending, and no settlement fund exists.
- A separate shareholder class action has a lead plaintiff deadline of November 2, 2026, for investors only.
If you’ve seen headlines about a “Hims lawsuit,” you’re not imagining it. The Federal Trade Commission actually sued the telehealth company, and the filing is public record.
This isn’t a scam text or a fake claim site. It’s a genuine federal enforcement action tied to how Hims & Hers handled customer health data and subscription billing.
This article breaks down what the FTC alleges, who’s affected, what money (if any) is on the table, and the one date investors need to know. One detail stands out: the agency says it investigated this company for nearly three years before filing.
The Facts
| Category | Detail |
|---|---|
| Case | FTC, State of Utah, and Los Angeles County (for California) v. Hims & Hers Health, Inc. |
| Court | U.S. District Court for the Northern District of California |
| Case Number | Not yet confirmed in public reporting |
| Status | Complaint filed, case active, no settlement reached |
| Fund Size | Not applicable, no monetary amount has been specified |
| Est. Per Person | Not yet determined |
| Claim Deadline | None yet, no consumer claims process exists |
| Administrator | Not yet appointed |
| Related Case | Separate securities class action, lead plaintiff deadline November 2, 2026 |
Is the Hims lawsuit real or a scam?
The Hims lawsuit is real. It’s a federal enforcement action filed by the FTC, not a scam text or phishing scheme.
The FTC announced the case in an official press release on July 29, 2026. Utah’s Division of Consumer Protection and Los Angeles County Counsel, acting for California, joined as co-plaintiffs.
If you received a text or email claiming you can “claim your Hims settlement money” right now, be skeptical. No settlement fund exists yet, and no legitimate notice would ask for payment to file.
Key Takeaway: The FTC’s case against Hims & Hers is a confirmed federal lawsuit, but no consumer payout process exists as of this writing.
Is this a class action lawsuit?
The FTC case itself is a government enforcement action, not a class action, so there’s no group of consumers formally certified as a class in that filing.
However, a separate securities class action was filed against Hims & Hers on behalf of investors. That case covers shareholders who bought stock between August 4, 2025 and July 29, 2026.
Here’s how the two differ:
| Case Type | Who It Covers | Filed By |
|---|---|---|
| FTC enforcement action | General consumers and the public interest | FTC, Utah, Los Angeles County |
| Securities class action | Investors who bought HIMS stock in the class period | Multiple law firms on behalf of shareholders |
Regular customers of Hims & Hers are not currently part of a certified consumer class action tied to this FTC case.
How much money could I get from the Hims lawsuit?
Not yet determined. The FTC’s complaint does not specify a dollar amount, and no settlement or judgment has been reached.
The FTC is seeking a permanent injunction, restitution, civil penalties, and other monetary relief. That’s standard enforcement language, but it doesn’t translate to an automatic payout for individual customers.
One data point offers context. In May 2026, before the lawsuit was filed, Hims & Hers disclosed a $15 million probable-loss accrual tied to the FTC investigation and warned the final cost could run higher.
That $15 million figure is an accounting estimate, not a confirmed settlement or per-customer payment. Think of it like a company setting aside cash for a possible parking ticket before the judge has even ruled.
Reality Check: No one legitimately texts you out of nowhere to claim Hims settlement money right now. Filing any real consumer claim is always free. Be wary of any third party charging a fee to “process” a claim that doesn’t exist yet.
Do Hims & Hers shareholders qualify for a payout?
Shareholders who bought Hims & Hers stock between August 4, 2025 and July 29, 2026, may have grounds to participate in the securities class action, separate from the FTC case.
The class period covers the stretch when the company allegedly made misleading statements about its privacy and billing practices, right up to the day the FTC’s lawsuit became public.
Key Takeaway: This securities case is about investment losses, not consumer refunds. It only applies if you owned HIMS stock during the specified window.
On the day the FTC lawsuit was announced, HIMS shares dropped $4.32, or 14.73 percent, closing at $25.00. That single-day crash is the financial event driving the shareholder lawsuit.
Multiple law firms, including Glancy Prongay Wolke & Rotter and the Law Offices of Howard G. Smith, have issued public notices seeking lead plaintiffs for this case.
How do I file a claim or join the Hims lawsuit?
Right now, there’s no consumer claim form to fill out, because no consumer settlement fund exists.
If you’re a shareholder considering the securities case, the general process for these lawsuits typically works like this:
- Confirm you purchased HIMS stock within the August 4, 2025 to July 29, 2026 window
- Gather brokerage statements showing your purchase dates and share amounts
- Contact one of the law firms publicly involved in the case if you want to seek lead plaintiff status
- Understand that being lead plaintiff is optional. You don’t need that role to eventually share in any recovery
- Watch for official court notices if the case proceeds toward settlement or judgment
- Ignore any unsolicited message asking for payment to “register” your claim
For general consumers of Hims & Hers products, there’s currently no action to take. Watch official channels rather than clicking links from unverified emails or texts.
What is the deadline to join the lawsuit?
The only confirmed deadline right now is November 2, 2026, and it applies only to the securities class action.
That date is the court-set deadline for shareholders to file a motion seeking appointment as lead plaintiff in the investor case. Missing it doesn’t disqualify you from any eventual recovery, but it does remove your chance to serve as lead plaintiff.
There is no deadline for general consumers because no consumer claims process has been established. If the FTC case eventually leads to a settlement with a consumer restitution component, a new deadline would be announced separately.
What is the latest update on the Hims lawsuit?
As of early September 2026, the FTC case remains in its early stages, and no settlement has been reached.
Hims & Hers publicly responded the same day the lawsuit was filed, calling it an attempt to “generate headlines” rather than legitimate enforcement.
Meanwhile, the securities class action is actively recruiting a lead plaintiff, with multiple firms issuing investor notices through early September. Separately, at least one firm has announced it’s investigating Hims & Hers over a data breach angle tied to the same underlying facts.
Key Takeaway: Two separate legal tracks are moving in parallel: the FTC’s consumer protection case and a private securities class action for investors.
What has Hims & Hers said in response?
Hims & Hers has denied wrongdoing and says it will fight the FTC’s claims in court.
The company’s official statement argued the FTC “disregarded substantial evidence” gathered during a nearly three-year investigation and called the case an effort to generate headlines rather than protect consumers.
The company also pointed to its privacy policy, saying it allows patients to control how their data is used, and framed the lawsuit as inconsistent with existing telehealth industry standards.
What does the FTC’s complaint actually allege?
The FTC alleges Hims & Hers deceived consumers about privacy protections and made subscription billing hard to escape.
The complaint centers on three main claims:
- Health data sharing: Hims & Hers allegedly shared sensitive health information, including details tied to medical conditions, with third-party advertising platforms like Meta and Snap, despite marketing itself as private and discreet.
- Deceptive billing: The company allegedly advertised free consultations and “Pay $0 today,” then charged customers before a provider actually reviewed their treatment, sometimes immediately after an intake form was submitted.
- Hard-to-cancel subscriptions: The FTC says cancellation was buried behind multiple menus and retention screens rather than offered clearly.
One example cited in reporting: a customer was reportedly charged $897 before ever speaking with a medical provider.
Why is Hims being sued over data privacy specifically?
Hims & Hers is being sued because regulators allege its actual data practices contradicted its public privacy promises.
The company marketed its telehealth services as “100% online, private, and secure,” according to the complaint. The FTC alleges that promise didn’t match reality once tracking pixels and third-party ad platforms entered the picture.
This isn’t happening in isolation. It’s part of a broader wave of FTC scrutiny into how digital health companies handle sensitive user data in 2026, alongside continued enforcement under laws like ROSCA.
What laws does the lawsuit claim were violated?
The complaint cites violations of the FTC Act and the Restore Online Shoppers’ Confidence Act (ROSCA) at the federal level.
| Law | Alleged Violation | Filed By |
|---|---|---|
| FTC Act | Deceptive privacy and billing practices | FTC |
| ROSCA | Failing to disclose subscription terms clearly | FTC |
| California false advertising and unfair competition laws | State-level deceptive practices | Los Angeles County Counsel |
| Utah Consumer Sales Practices Act | Deceptive sales practices | Utah Division of Consumer Protection |
This multi-jurisdiction structure is why both a federal agency and two state-level authorities appear on the same complaint.
Who is affected by the Hims lawsuit?
Anyone who used Hims & Hers services and had health data shared with third parties, or was charged before a provider consultation, falls within the scope of the FTC’s allegations.
Hims & Hers offers online treatment for sexual health, hair loss, skin conditions, mental health, and weight loss. Customers submit an intake form reviewed by a contracted provider before receiving prescriptions.
The FTC alleges “hundreds of thousands of consumers” were affected by the billing practices described in the complaint, though that figure comes from the agency, not an independently verified count.
What is Hims & Hers Health, Inc.?
Hims & Hers Health, Inc. (NYSE: HIMS) is a publicly traded telehealth company that has operated since 2017, connecting consumers with providers online.
The company built its brand around convenience and privacy, marketing itself heavily through advertising, including national campaigns like Super Bowl commercials. It has also faced separate scrutiny over compounded weight loss medications in recent years.
This background matters because both the FTC case and the securities lawsuit hinge on the gap between that public brand image and the practices regulators say they found.
What Happens Next
- Filed July 29, 2026: FTC complaint filed in the Northern District of California.
- November 2, 2026: Deadline for shareholders to seek lead plaintiff status in the securities class action.
- Expected late 2026: Continued pretrial motions and discovery in the FTC case, no trial date confirmed yet.
- TBD: Any settlement announcement, which would trigger a separate consumer claims process if restitution is included.
- TBD: Ruling on lead plaintiff appointment in the securities case following the November deadline.
Frequently Asked Questions
Is the Hims lawsuit legit?
Yes, it’s a real federal lawsuit filed by the FTC on July 29, 2026.
Utah and Los Angeles County (representing California) joined as co-plaintiffs.
This is public court record, not a scam.
Can I file a claim in the Hims lawsuit right now?
No, there’s currently no consumer claims process or settlement fund.
The FTC case is still active, with no judgment or settlement reached.
Watch official FTC and court channels for updates.
How much is the Hims & Hers settlement worth?
There is no confirmed settlement amount as of September 2026.
Hims & Hers previously disclosed a $15 million accrual, but that’s not a final payout figure.
Any eventual settlement terms would come from the court or FTC directly.
What is the deadline for the Hims lawsuit?
The only confirmed deadline is November 2, 2026, for the separate shareholder securities case.
There is no deadline yet for general consumers because no claims process exists.
Why is Hims & Hers being sued?
The FTC alleges the company shared sensitive health data with advertisers like Meta and Snap.
It also alleges deceptive billing and difficult subscription cancellation.
Hims & Hers denies wrongdoing and says it will fight the case.
Is this the same as the Hims weight loss drug lawsuit?
No, this FTC case focuses on data privacy and billing practices, not medication safety claims.
Hims & Hers has faced separate scrutiny over compounded weight loss drugs in other contexts.
Will Hims & Hers customers get money back?
Not currently. No consumer restitution has been ordered or agreed to.
If the FTC case settles with a consumer relief component, a new claims process would be announced.
Who can join the securities class action?
Investors who purchased HIMS stock between August 4, 2025 and July 29, 2026, may have standing.
This applies to shareholders, not general telehealth customers.
Nothing here means you’re owed money yet, and no legitimate source will ask you to pay to find out. If you’re an affected shareholder, the one date to calendar is November 2, 2026.
For everyone else, the smartest move is watching the official FTC case docket and ignoring unsolicited “claim your payout” messages until an actual settlement exists.
